Global Friedreich Ataxia Drug Market Research Report 2023

Report ID: 1970246 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Friedreich Ataxia Drug Market Overview
    1.1 Product Overview and Scope of Friedreich Ataxia Drug
    1.2 Friedreich Ataxia Drug Segment by Type
        1.2.1 Global Friedreich Ataxia Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 ADVM-063
        1.2.3 AGIL-FA
        1.2.4 BHV-4157
        1.2.5 BVA-202
        1.2.6 Others
    1.3 Friedreich Ataxia Drug Segment by Application
        1.3.1 Global Friedreich Ataxia Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Friedreich Ataxia Drug Market Size Estimates and Forecasts
        1.4.1 Global Friedreich Ataxia Drug Revenue 2017-2028
        1.4.2 Global Friedreich Ataxia Drug Sales 2017-2028
        1.4.3 Friedreich Ataxia Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Friedreich Ataxia Drug Market Competition by Manufacturers
    2.1 Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Friedreich Ataxia Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Friedreich Ataxia Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Friedreich Ataxia Drug Manufacturing Sites, Area Served, Product Type
    2.5 Friedreich Ataxia Drug Market Competitive Situation and Trends
        2.5.1 Friedreich Ataxia Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Friedreich Ataxia Drug Players Market Share by Revenue
        2.5.3 Global Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Friedreich Ataxia Drug Retrospective Market Scenario by Region
    3.1 Global Friedreich Ataxia Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Friedreich Ataxia Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Friedreich Ataxia Drug Market Facts & Figures by Country
        3.3.1 North America Friedreich Ataxia Drug Sales by Country
        3.3.2 North America Friedreich Ataxia Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Friedreich Ataxia Drug Market Facts & Figures by Country
        3.4.1 Europe Friedreich Ataxia Drug Sales by Country
        3.4.2 Europe Friedreich Ataxia Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Friedreich Ataxia Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Friedreich Ataxia Drug Sales by Region
        3.5.2 Asia Pacific Friedreich Ataxia Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Friedreich Ataxia Drug Market Facts & Figures by Country
        3.6.1 Latin America Friedreich Ataxia Drug Sales by Country
        3.6.2 Latin America Friedreich Ataxia Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Friedreich Ataxia Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Friedreich Ataxia Drug Sales by Country
        3.7.2 Middle East and Africa Friedreich Ataxia Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Friedreich Ataxia Drug Historic Market Analysis by Type
    4.1 Global Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)
    4.2 Global Friedreich Ataxia Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Friedreich Ataxia Drug Price by Type (2017-2022)
5 Global Friedreich Ataxia Drug Historic Market Analysis by Application
    5.1 Global Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)
    5.2 Global Friedreich Ataxia Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Friedreich Ataxia Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Adverum Biotechnologies Inc
        6.1.1 Adverum Biotechnologies Inc Corporation Information
        6.1.2 Adverum Biotechnologies Inc Description and Business Overview
        6.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Portfolio
        6.1.5 Adverum Biotechnologies Inc Recent Developments/Updates
    6.2 BioMarin Pharmaceutical Inc.
        6.2.1 BioMarin Pharmaceutical Inc. Corporation Information
        6.2.2 BioMarin Pharmaceutical Inc. Description and Business Overview
        6.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Portfolio
        6.2.5 BioMarin Pharmaceutical Inc. Recent Developments/Updates
    6.3 Biovista Inc.
        6.3.1 Biovista Inc. Corporation Information
        6.3.2 Biovista Inc. Description and Business Overview
        6.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Biovista Inc. Friedreich Ataxia Drug Product Portfolio
        6.3.5 Biovista Inc. Recent Developments/Updates
    6.4 Cardero Therapeutics Inc
        6.4.1 Cardero Therapeutics Inc Corporation Information
        6.4.2 Cardero Therapeutics Inc Description and Business Overview
        6.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
        6.4.5 Cardero Therapeutics Inc Recent Developments/Updates
    6.5 Catabasis Pharmaceuticals, Inc.
        6.5.1 Catabasis Pharmaceuticals, Inc. Corporation Information
        6.5.2 Catabasis Pharmaceuticals, Inc. Description and Business Overview
        6.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Portfolio
        6.5.5 Catabasis Pharmaceuticals, Inc. Recent Developments/Updates
    6.6 Forward Pharma A/S
        6.6.1 Forward Pharma A/S Corporation Information
        6.6.2 Forward Pharma A/S Description and Business Overview
        6.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Forward Pharma A/S Friedreich Ataxia Drug Product Portfolio
        6.6.5 Forward Pharma A/S Recent Developments/Updates
    6.7 Ixchel Pharma LLC
        6.6.1 Ixchel Pharma LLC Corporation Information
        6.6.2 Ixchel Pharma LLC Description and Business Overview
        6.6.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Ixchel Pharma LLC Friedreich Ataxia Drug Product Portfolio
        6.7.5 Ixchel Pharma LLC Recent Developments/Updates
    6.8 Pfizer Inc
        6.8.1 Pfizer Inc Corporation Information
        6.8.2 Pfizer Inc Description and Business Overview
        6.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Pfizer Inc Friedreich Ataxia Drug Product Portfolio
        6.8.5 Pfizer Inc Recent Developments/Updates
    6.9 ProQR Therapeutics NV
        6.9.1 ProQR Therapeutics NV Corporation Information
        6.9.2 ProQR Therapeutics NV Description and Business Overview
        6.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Product Portfolio
        6.9.5 ProQR Therapeutics NV Recent Developments/Updates
    6.10 RaNA Therapeutics Inc
        6.10.1 RaNA Therapeutics Inc Corporation Information
        6.10.2 RaNA Therapeutics Inc Description and Business Overview
        6.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
        6.10.5 RaNA Therapeutics Inc Recent Developments/Updates
    6.11 Reata Pharmaceuticals Inc
        6.11.1 Reata Pharmaceuticals Inc Corporation Information
        6.11.2 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Description and Business Overview
        6.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Portfolio
        6.11.5 Reata Pharmaceuticals Inc Recent Developments/Updates
    6.12 Retrotope Inc
        6.12.1 Retrotope Inc Corporation Information
        6.12.2 Retrotope Inc Friedreich Ataxia Drug Description and Business Overview
        6.12.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Retrotope Inc Friedreich Ataxia Drug Product Portfolio
        6.12.5 Retrotope Inc Recent Developments/Updates
    6.13 Takeda
        6.13.1 Takeda Corporation Information
        6.13.2 Takeda Friedreich Ataxia Drug Description and Business Overview
        6.13.3 Takeda Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Takeda Friedreich Ataxia Drug Product Portfolio
        6.13.5 Takeda Recent Developments/Updates
    6.14 STATegics Inc
        6.14.1 STATegics Inc Corporation Information
        6.14.2 STATegics Inc Friedreich Ataxia Drug Description and Business Overview
        6.14.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 STATegics Inc Friedreich Ataxia Drug Product Portfolio
        6.14.5 STATegics Inc Recent Developments/Updates
    6.15 Voyager Therapeutics Inc
        6.15.1 Voyager Therapeutics Inc Corporation Information
        6.15.2 Voyager Therapeutics Inc Friedreich Ataxia Drug Description and Business Overview
        6.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
        6.15.5 Voyager Therapeutics Inc Recent Developments/Updates
7 Friedreich Ataxia Drug Manufacturing Cost Analysis
    7.1 Friedreich Ataxia Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Friedreich Ataxia Drug
    7.4 Friedreich Ataxia Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Friedreich Ataxia Drug Distributors List
    8.3 Friedreich Ataxia Drug Customers
9 Friedreich Ataxia Drug Market Dynamics
    9.1 Friedreich Ataxia Drug Industry Trends
    9.2 Friedreich Ataxia Drug Market Drivers
    9.3 Friedreich Ataxia Drug Market Challenges
    9.4 Friedreich Ataxia Drug Market Restraints
10 Global Market Forecast
    10.1 Friedreich Ataxia Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Friedreich Ataxia Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Friedreich Ataxia Drug by Type (2023-2028)
    10.2 Friedreich Ataxia Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Friedreich Ataxia Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Friedreich Ataxia Drug by Application (2023-2028)
    10.3 Friedreich Ataxia Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Friedreich Ataxia Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Friedreich Ataxia Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Friedreich Ataxia Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Friedreich Ataxia Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Friedreich Ataxia Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Friedreich Ataxia Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Friedreich Ataxia Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Friedreich Ataxia Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Friedreich Ataxia Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Friedreich Ataxia Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Friedreich Ataxia Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Friedreich Ataxia Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Friedreich Ataxia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Friedreich Ataxia Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Friedreich Ataxia Drug Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Friedreich Ataxia Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Friedreich Ataxia Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Friedreich Ataxia Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Friedreich Ataxia Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Friedreich Ataxia Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Friedreich Ataxia Drug Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Friedreich Ataxia Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Friedreich Ataxia Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Friedreich Ataxia Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Friedreich Ataxia Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Friedreich Ataxia Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Friedreich Ataxia Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Friedreich Ataxia Drug Revenue Share by Type (2017-2022)
    Table 43. Global Friedreich Ataxia Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Friedreich Ataxia Drug Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Friedreich Ataxia Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Friedreich Ataxia Drug Revenue Share by Application (2017-2022)
    Table 48. Global Friedreich Ataxia Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Adverum Biotechnologies Inc Corporation Information
    Table 50. Adverum Biotechnologies Inc Description and Business Overview
    Table 51. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product
    Table 53. Adverum Biotechnologies Inc Recent Developments/Updates
    Table 54. BioMarin Pharmaceutical Inc. Corporation Information
    Table 55. BioMarin Pharmaceutical Inc. Description and Business Overview
    Table 56. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product
    Table 58. BioMarin Pharmaceutical Inc. Recent Developments/Updates
    Table 59. Biovista Inc. Corporation Information
    Table 60. Biovista Inc. Description and Business Overview
    Table 61. Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Biovista Inc. Friedreich Ataxia Drug Product
    Table 63. Biovista Inc. Recent Developments/Updates
    Table 64. Cardero Therapeutics Inc Corporation Information
    Table 65. Cardero Therapeutics Inc Description and Business Overview
    Table 66. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Cardero Therapeutics Inc Friedreich Ataxia Drug Product
    Table 68. Cardero Therapeutics Inc Recent Developments/Updates
    Table 69. Catabasis Pharmaceuticals, Inc. Corporation Information
    Table 70. Catabasis Pharmaceuticals, Inc. Description and Business Overview
    Table 71. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product
    Table 73. Catabasis Pharmaceuticals, Inc. Recent Developments/Updates
    Table 74. Forward Pharma A/S Corporation Information
    Table 75. Forward Pharma A/S Description and Business Overview
    Table 76. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Forward Pharma A/S Friedreich Ataxia Drug Product
    Table 78. Forward Pharma A/S Recent Developments/Updates
    Table 79. Ixchel Pharma LLC Corporation Information
    Table 80. Ixchel Pharma LLC Description and Business Overview
    Table 81. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Ixchel Pharma LLC Friedreich Ataxia Drug Product
    Table 83. Ixchel Pharma LLC Recent Developments/Updates
    Table 84. Pfizer Inc Corporation Information
    Table 85. Pfizer Inc Description and Business Overview
    Table 86. Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. Pfizer Inc Friedreich Ataxia Drug Product
    Table 88. Pfizer Inc Recent Developments/Updates
    Table 89. ProQR Therapeutics NV Corporation Information
    Table 90. ProQR Therapeutics NV Description and Business Overview
    Table 91. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. ProQR Therapeutics NV Friedreich Ataxia Drug Product
    Table 93. ProQR Therapeutics NV Recent Developments/Updates
    Table 94. RaNA Therapeutics Inc Corporation Information
    Table 95. RaNA Therapeutics Inc Description and Business Overview
    Table 96. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. RaNA Therapeutics Inc Friedreich Ataxia Drug Product
    Table 98. RaNA Therapeutics Inc Recent Developments/Updates
    Table 99. Reata Pharmaceuticals Inc Corporation Information
    Table 100. Reata Pharmaceuticals Inc Description and Business Overview
    Table 101. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 102. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product
    Table 103. Reata Pharmaceuticals Inc Recent Developments/Updates
    Table 104. Retrotope Inc Corporation Information
    Table 105. Retrotope Inc Description and Business Overview
    Table 106. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 107. Retrotope Inc Friedreich Ataxia Drug Product
    Table 108. Retrotope Inc Recent Developments/Updates
    Table 109. Takeda Corporation Information
    Table 110. Takeda Description and Business Overview
    Table 111. Takeda Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 112. Takeda Friedreich Ataxia Drug Product
    Table 113. Takeda Recent Developments/Updates
    Table 114. STATegics Inc Corporation Information
    Table 115. STATegics Inc Description and Business Overview
    Table 116. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 117. STATegics Inc Friedreich Ataxia Drug Product
    Table 118. STATegics Inc Recent Developments/Updates
    Table 119. Voyager Therapeutics Inc Corporation Information
    Table 120. Voyager Therapeutics Inc Description and Business Overview
    Table 121. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 122. Voyager Therapeutics Inc Friedreich Ataxia Drug Product
    Table 123. Voyager Therapeutics Inc Recent Developments/Updates
    Table 124. Production Base and Market Concentration Rate of Raw Material
    Table 125. Key Suppliers of Raw Materials
    Table 126. Friedreich Ataxia Drug Distributors List
    Table 127. Friedreich Ataxia Drug Customers List
    Table 128. Friedreich Ataxia Drug Market Trends
    Table 129. Friedreich Ataxia Drug Market Drivers
    Table 130. Friedreich Ataxia Drug Market Challenges
    Table 131. Friedreich Ataxia Drug Market Restraints
    Table 132. Global Friedreich Ataxia Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 133. Global Friedreich Ataxia Drug Sales Market Share Forecast by Type (2023-2028)
    Table 134. Global Friedreich Ataxia Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 135. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 136. Global Friedreich Ataxia Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 137. Global Friedreich Ataxia Drug Sales Market Share Forecast by Application (2023-2028)
    Table 138. Global Friedreich Ataxia Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 139. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 140. Global Friedreich Ataxia Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 141. Global Friedreich Ataxia Drug Sales Market Share Forecast by Region (2023-2028)
    Table 142. Global Friedreich Ataxia Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 143. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Friedreich Ataxia Drug
    Figure 2. Global Friedreich Ataxia Drug Market Share by Type in 2021 & 2028
    Figure 3. ADVM-063 Product Picture
    Figure 4. AGIL-FA Product Picture
    Figure 5. BHV-4157 Product Picture
    Figure 6. BVA-202 Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Friedreich Ataxia Drug Market Share by Application in 2021 & 2028
    Figure 9. Clinic
    Figure 10. Hospital
    Figure 11. Others
    Figure 12. Global Friedreich Ataxia Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Friedreich Ataxia Drug Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Friedreich Ataxia Drug Sales (2017-2028) & (K Pcs)
    Figure 15. Friedreich Ataxia Drug Sales Share by Manufacturers in 2021
    Figure 16. Global Friedreich Ataxia Drug Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Friedreich Ataxia Drug Players: Market Share by Revenue in 2021
    Figure 18. Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Friedreich Ataxia Drug Sales Market Share by Region (2017-2022)
    Figure 20. Global Friedreich Ataxia Drug Sales Market Share by Region in 2021
    Figure 21. Global Friedreich Ataxia Drug Revenue Market Share by Region (2017-2022)
    Figure 22. Global Friedreich Ataxia Drug Revenue Market Share by Region in 2021
    Figure 23. U.S. Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. UAE Friedreich Ataxia Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Friedreich Ataxia Drug by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Friedreich Ataxia Drug
    Figure 49. Manufacturing Process Analysis of Friedreich Ataxia Drug
    Figure 50. Friedreich Ataxia Drug Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Takeda
STATegics Inc
Voyager Therapeutics Inc
Frequently Asked Questions
Friedreich Ataxia Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Friedreich Ataxia Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Friedreich Ataxia Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aurora Kinase A

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More